Cancer Family
Gastric Neoplasm
CI-CAN-00000185Explore in graph →
Non-malignant718 active trials4 approved drugs55 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000185Explore in graph →
Clinical trials
3,260 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05649163 | Real-world Study of HER2-overexpressed Advanced Solid Tumors After Progression of First-line Standard Therapy | unknown | — | 306 | Shen LinOTHER | 1 | Dec 16, 2022 | clinicaltrials |
| NCT05647941 | Neo-adjuvant Chemotherapy Evluation in Gastric Cancer Patients Based on Circulating Exosomal LncRNA-GC1 | unknown | — | 700 | Chinese PLA General HospitalOTHER | 1 | Dec 14, 2022 | clinicaltrials |
| NCT05643677 | Fruquintinib Plus Irinotecan in the Treatment of Advanced Gastric Cancer | unknown | Phase 2 | 47 | Fujian Medical UniversityOTHER | 0 | Dec 9, 2022 | clinicaltrials |
| NCT05645198 | The Effect of Carboxymetyl Starch (Oozfix) on Preventing Postoperative Complication After Gastrectomy(OOZFIX) | unknown | Phase 4 | 180 | Bucheon St. Mary's HospitalOTHER | 1 | Dec 9, 2022 | clinicaltrials |
| NCT04077255 | EGFR-targeted Therapy for Gastric Cancer | unknown | Phase 2 | 19 | National Cancer Center, KoreaOTHER_GOV | 1 | Nov 30, 2022 | clinicaltrials |
| NCT04893252 | Vactosertib and Durvalumab in Gastric Cancer | unknown | Phase 2 | 55 | Hark Kyun KimOTHER_GOV | 1 | Nov 30, 2022 | clinicaltrials |
| NCT05619016 | [68Ga]Ga-ABY-025 PET for Quantification of HER2-status in Solid Tumors | unknown | Phase 2 | 72 | Karolinska University HospitalOTHER | 1 | Nov 30, 2022 | clinicaltrials |
| NCT05631015 | Artificial Intelligence for Determination of Gastroscopy Surveillance Intervals | unknown | — | 2,000 | Xiuli ZuoOTHER | 1 | Nov 30, 2022 | clinicaltrials |
| NCT05627414 | Conversion Therapy of Disitamab Vedotin Combined With Sintilimab and S-1 in HER2 Overexpression Gastric Cancer | unknown | Phase 2 | 30 | Tianjin Medical University Cancer Institute and HospitalOTHER | 0 | Nov 25, 2022 | clinicaltrials |
| NCT05415098 | Study of Safety, Pharmacokinetic and Efficacy of APG-5918 in Advanced Solid Tumors or Lymphomas | unknown | Phase 1 | 90 | Ascentage Pharma Group Inc.INDUSTRY | 1 | Nov 16, 2022 | clinicaltrials |
| NCT04744649 | Neoadjuvant Immunotherapy and Chemotherapy for Locally Advanced Esophagogastric Junction and Gastric Cancer Trial(NICE) | unknown | Phase 2 | 110 | Nanfang Hospital, Southern Medical UniversityOTHER | 1 | Nov 15, 2022 | clinicaltrials |
| NCT05617469 | DLCS for Predicting Neoadjuvant Chemotherapy Response | unknown | — | 1,100 | Zhejiang Cancer HospitalOTHER | 1 | Nov 15, 2022 | clinicaltrials |
| NCT05385809 | A Retrospective Study of Immunotherapy in Conversion Therapy of Unresectable Gastric Cancer | unknown | — | 100 | Zhejiang Cancer HospitalOTHER | 1 | Nov 9, 2022 | clinicaltrials |
| NCT05608785 | Single-center, Multi-cohort Exploratory Phase Ib/II Clinical Study of First-line Treatment of Unresectable Locally Advanced/Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction Based on Different Genotypes | unknown | Phase 1 / Phase 2 | 45 | Henan Cancer HospitalOTHER_GOV | 0 | Nov 8, 2022 | clinicaltrials |
| NCT02679495 | Lifestyle Intervention for Prevention of Gastric Neoplasm | unknown | N/A | 350 | Shandong UniversityOTHER | 1 | Nov 7, 2022 | clinicaltrials |
| NCT05600608 | Augmentation of Volatile Biomarkers of Oesophageal and Gastric Adenocarcinoma From the Tumour Lipidome(AVOCADO) | unknown | N/A | 100 | Anuja MitraOTHER | 1 | Nov 2, 2022 | clinicaltrials |
| NCT04907591 | Postoperative Prognosis Management Service Based mHealth for Gastric Cancer Patients | unknown | N/A | 324 | Samsung Medical CenterOTHER | 1 | Oct 26, 2022 | clinicaltrials |
| NCT05594381 | A Biomarker Study for Predicting the Efficacy of Neoadjuvant Sintilimab Plus SOX for Gastric Adenocarcinoma. | unknown | Phase 2 | 90 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 0 | Oct 26, 2022 | clinicaltrials |
| NCT05587088 | Evaluation of the Safety and Efficacy of Esperanza Extract (PA001)(PA001) | unknown | Phase 1 / Phase 2 | 82 | Hospital Universitario San IgnacioOTHER | 1 | Oct 19, 2022 | clinicaltrials |
| NCT05584592 | A Randomized Controlled Trial of Integrated Early Palliative Care for Advanced Gastric Cancer Patients | unknown | N/A | 170 | Yonsei UniversityOTHER | 1 | Oct 18, 2022 | clinicaltrials |
| NCT04727034 | Efficacy and Safety of Remimazolam Tosylate for Sedation in Gastroscopy | unknown | N/A | 1,800 | RenJi HospitalOTHER | 1 | Oct 12, 2022 | clinicaltrials |
| NCT04574245 | Gastric Cancer Liver Metastasis Cohort of China(RECORD) | unknown | — | 3,000 | Chinese PLA General HospitalOTHER | 1 | Oct 5, 2022 | clinicaltrials |
| NCT05550974 | Articulated Laparoscopic Instruments Clinical Study | unknown | — | 1,155 | Yonsei UniversityOTHER | 1 | Oct 3, 2022 | clinicaltrials |
| NCT05545436 | Carrelizumab (PD-1) Combined With Chemotherapy in Neoadjuvant Treatment of Locally Advanced Gastric Cancer | unknown | Phase 2 | 34 | Third Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 1 | Sep 22, 2022 | clinicaltrials |
| NCT05543863 | Pharmacokinetics of Oral Antiplatelet Agents After Distal Gastrectomy | unknown | — | 20 | Kyungpook National University Chilgok HospitalOTHER | 1 | Sep 21, 2022 | clinicaltrials |
| NCT05540119 | Swedish Oesophago-Gastric Study(SOEGAS) | unknown | — | 25,000 | Karolinska InstitutetOTHER | 1 | Sep 19, 2022 | clinicaltrials |
| NCT05528367 | Tirelizumab in Combination With Chemoradiation in Patients With Unresectable Gastric Cancer or Gastroesophageal Junction Adenocarcinoma | unknown | Phase 2 | 33 | Zhejiang Cancer HospitalOTHER | 1 | Sep 6, 2022 | clinicaltrials |
| NCT05526339 | HFNO Combined With NPA Reduces Hypoxia During Sedated Gastrointestinal Endoscopy In Obese Patients | unknown | N/A | 600 | RenJi HospitalOTHER | 1 | Sep 2, 2022 | clinicaltrials |
| NCT05253716 | Immunonutritional Supplement After Total Gastrectomy in Patients With Stage III Gastric Cancer(CRUCIAL) | unknown | N/A | 696 | Jinling Hospital, ChinaOTHER | 1 | Aug 29, 2022 | clinicaltrials |
| NCT05519202 | Exploratory Clinical Study of Penpulimab Combined With SOX in the Perioperative Treatment of Gastric Cancer | unknown | Phase 2 | 47 | The Central Hospital of Lishui CityOTHER | 0 | Aug 29, 2022 | clinicaltrials |
| NCT05510388 | HFNO Reduces Hypoxia During Sedated Gastroscopy or Colonoscopy in High Risk Patients(HRISK) | unknown | N/A | 450 | RenJi HospitalOTHER | 1 | Aug 22, 2022 | clinicaltrials |
| NCT05024812 | Fruquintinib Combined With Toripalimab and SOX Regimen in the First-line Treatment of Advanced Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma | unknown | Phase 1 / Phase 2 | 64 | The First Affiliated Hospital of Zhengzhou UniversityOTHER | 1 | Aug 18, 2022 | clinicaltrials |
| NCT05497739 | Intraperitoneal Chemotherapy Guided by the Detection of DNA in Peritoneal Lavage Fluid in Patients With Gastric Cancer | unknown | Phase 2 | 68 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Aug 11, 2022 | clinicaltrials |
| NCT05498194 | Computational Prediction and Experimental Validation of Gastric Cancer Associated Neoantigens | unknown | — | 50 | University Medical Center Ho Chi Minh City (UMC)OTHER | 1 | Aug 11, 2022 | clinicaltrials |
| NCT05442138 | A Study on the Potential Benefit of Neoadjuvant Therapy for AGC Patients | unknown | — | 54 | Henan Cancer HospitalOTHER_GOV | 0 | Jul 29, 2022 | clinicaltrials |
| NCT05445401 | Pre-rehabilitation in Neoadjuvant Patients With Gastric Cancer | unknown | N/A | 30 | The First Hospital of Jilin UniversityOTHER | 0 | Jul 27, 2022 | clinicaltrials |
| NCT05470452 | Validating the Safety and Effectiveness of ENDOANGEL Upper Gastrointestinal Endoscope Image Auxiliary Diagnostic Software | unknown | N/A | 340 | The Second Affiliated Hospital of Chongqing Medical UniversityOTHER | 1 | Jul 22, 2022 | clinicaltrials |
| NCT05439993 | Tepotinib Plus Paclitaxel in MET Amplified or MET Exon 14 Alterated Gastric and GEJ Carcinoma | unknown | Phase 1 / Phase 2 | 42 | Hallym University Medical CenterOTHER | 1 | Jul 5, 2022 | clinicaltrials |
| NCT05019794 | Infigratinib in Subjects With GC or GEJ With FGFR2 Amplification or Other Solid Tumors With Other FGFR Alterations(FGFR) | unknown | Phase 2 | 80 | LianBio LLCINDUSTRY | 1 | Jun 27, 2022 | clinicaltrials |
| NCT05397548 | Use of Circulating Exosomal LncRNA-GC1 to Monitor Gastric Cancer(UCELMGC) | unknown | — | 700 | Lin ChenOTHER | 1 | Jun 27, 2022 | clinicaltrials |
| NCT05410847 | Nab-paclitaxel Plus Camrelizumab and S-1 Conversion Therapy for Gastric Cancer With Positive Exfoliative Cancer Cells | unknown | Phase 2 | 30 | Hebei Medical UniversityOTHER | 0 | Jun 24, 2022 | clinicaltrials |
| NCT05368636 | Combining Tongue and Gastric Cancer Cascade With Artificial Intelligence | unknown | — | 4,000 | Shandong UniversityOTHER | 1 | Jun 22, 2022 | clinicaltrials |
| NCT04637048 | Observational Study on Patients With Hepatobiliary Tumors | unknown | — | 1,000 | Gang Chen, MDOTHER | 1 | Jun 16, 2022 | clinicaltrials |
| NCT05411432 | Clinical Study of 68Ga Labeled HER2 Affibody Analogues | unknown | Early Phase 1 | 56 | Xijing HospitalOTHER | 0 | Jun 9, 2022 | clinicaltrials |
| NCT04139135 | A Clinical Study of HLX10 Combined With Chemotherapy Versus Placebo Combined With Chemotherapy for Neoadjuvant/Adjuvant Treatment of Gastric Cancer | unknown | Phase 3 | 642 | Shanghai Henlius BiotechINDUSTRY | 1 | Jun 6, 2022 | clinicaltrials |
| NCT05269056 | Early Detection of Gastric Cancer Using Plasma Cell-free DNA Fragmentomics | unknown | — | 300 | Zhejiang Cancer HospitalOTHER | 1 | Jun 2, 2022 | clinicaltrials |
| NCT05395780 | A Phase 2 Study to Evaluate the Safety and Efficacy of Max-40279-01 in Patients With Advanced Gastric Cancer or Gastroesophageal Junction Cancer | unknown | Phase 2 | 30 | Maxinovel Pty., Ltd.INDUSTRY | 1 | Jun 2, 2022 | clinicaltrials |
Data updated 23 days agoSource updated Dec 16, 2022source: clinicaltrials